Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MASI Stock Forecast 2025-2026
$154.39
Current Price
$8.30B
Market Cap
Buy 6
Hold 3
Sell 0
Wall St Analyst Ratings
Distance to MASI Price Targets
+29.5%
To High Target of $200.00
+18.2%
To Median Target of $182.50
+2.3%
To Low Target of $158.00
MASI Price Momentum
-1.4%
1 Week Change
+1.8%
1 Month Change
+28.0%
1 Year Change
-6.6%
Year-to-Date Change
-20.8%
From 52W High of $194.88
+51.9%
From 52W Low of $101.61
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Masimo (MASI) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on MASI and similar high-potential opportunities.
Latest MASI Stock Price Targets & Analyst Predictions
Based on our analysis of 12 Wall Street analysts, MASI has a bullish consensus with a median price target of $182.50 (ranging from $158.00 to $200.00). The overall analyst rating is Strong Buy (8.2/10). Currently trading at $154.39, the median forecast implies a 18.2% upside. This outlook is supported by 6 Buy, 3 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Jason Bednar at Piper Sandler, projecting a 29.5% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MASI Analyst Ratings
6
Buy
3
Hold
0
Sell
MASI Price Target Range
Low
$158.00
Average
$182.50
High
$200.00
Current: $154.39
Latest MASI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MASI.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 7, 2025 | Piper Sandler | Jason Bednar | Overweight | Reiterates | $200.00 |
| May 7, 2025 | Raymond James | Jayson Bedford | Outperform | Maintains | $185.00 |
| May 7, 2025 | Wells Fargo | Vik Chopra | Overweight | Maintains | $190.00 |
| Apr 10, 2025 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Feb 26, 2025 | Wells Fargo | Vik Chopra | Overweight | Maintains | $205.00 |
| Feb 26, 2025 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Feb 26, 2025 | Piper Sandler | Jason Bednar | Overweight | Maintains | $215.00 |
| Jan 22, 2025 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Jan 16, 2025 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Dec 27, 2024 | Raymond James | Jayson Bedford | Outperform | Maintains | $194.00 |
| Dec 18, 2024 | Piper Sandler | Jason Bednar | Overweight | Maintains | $210.00 |
| Dec 11, 2024 | Wells Fargo | Vik Chopra | Overweight | Maintains | $193.00 |
| Nov 22, 2024 | Stifel | Rick Wise | Buy | Reiterates | $190.00 |
| Nov 6, 2024 | Raymond James | Jayson Bedford | Outperform | Upgrade | $170.00 |
| Nov 6, 2024 | Piper Sandler | Jason Bednar | Overweight | Maintains | $180.00 |
| Nov 6, 2024 | Wells Fargo | Vik Chopra | Overweight | Maintains | $171.00 |
| Nov 6, 2024 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Oct 14, 2024 | BTIG | Marie Thibault | Buy | Maintains | $170.00 |
| Sep 25, 2024 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Sep 20, 2024 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
Masimo Corporation (MASI) Competitors
The following stocks are similar to Masimo based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Masimo Corporation (MASI) Financial Data
Masimo Corporation has a market capitalization of $8.30B with a P/E ratio of 129.2x. The company generates $2.13B in trailing twelve-month revenue with a -23.3% profit margin.
Revenue growth is +9.5% quarter-over-quarter, while maintaining an operating margin of +21.7% and return on equity of -25.1%.
Valuation Metrics
Market Cap
$8.30B
Enterprise Value
$8.85B
P/E Ratio
129.2x
PEG Ratio
33.0x
Price/Sales
3.9x
Growth & Margins
Revenue Growth (YoY)
+9.5%
Gross Margin
+62.9%
Operating Margin
+21.7%
Net Margin
-23.3%
EPS Growth
-24.5%
Financial Health
Cash/Price Ratio
+1.6%
Current Ratio
2.2x
Debt/Equity
72.0x
ROE
-25.1%
ROA
+1.3%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Masimo Corporation (MASI) Business Model
About Masimo Corporation
What They Do
Develops noninvasive monitoring technologies for healthcare.
Business Model
Masimo Corporation generates revenue primarily through the sale of advanced medical devices, particularly pulse oximetry systems, that enable healthcare providers to monitor patients' vital signs without invasive procedures. The company capitalizes on its proprietary technology to enhance patient outcomes and reduce healthcare costs, making its products essential in various medical settings.
Additional Information
Masimo's technology is recognized for its precision and reliability, even under challenging conditions, which enhances its adoption in hospitals and outpatient centers. The company is headquartered in Irvine, California, and is focused on expanding its range of health monitoring solutions to further improve global healthcare practices.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
3,600
CEO
Ms. Catherine M. Szyman
Country
United States
IPO Year
2007
Website
www.masimo.comMasimo Corporation (MASI) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Is Masimo (MASI) a Solid Growth Stock? 3 Reasons to Think "Yes"
Masimo (MASI) could produce exceptional returns because of its solid growth attributes.
May 08, 2025
By Zacks Equity Research
Tale of the Tape
Masimo (MASI) Q1 Earnings and Revenues Surpass Estimates
Masimo (MASI) delivered earnings and revenue surprises of 9.68% and 1.29%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
May 06, 2025
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
Masimo (MASI) is positioned for potential exceptional returns due to its strong growth attributes.
Why It Matters
Masimo’s strong growth potential suggests significant upside for investors, indicating potential for high returns and making it an attractive option in the market.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Samsung's Harman International will acquire Masimo's audio business for $350 million, enhancing its audio technology portfolio.
Why It Matters
Samsung's acquisition of Masimo's audio business signals a strategic expansion into audio technology, potentially enhancing product offerings and driving future revenue growth.
Source: Reuters
Market Sentiment:
Positive
Quick Summary
Masimo Corporation (NASDAQ: MASI) will hold its Q1 2025 earnings conference call on May 7, 2025, at 4:30 PM ET, featuring key executives and financial analysts.
Why It Matters
Masimo's Q1 2025 earnings call reveals insights on financial performance and strategic direction, critical for assessing investment potential and market positioning.
Source: Seeking Alpha
Market Sentiment:
Neutral
Masimo Reports First Quarter 2025 Results
9 days ago
Quick Summary
Masimo Corporation reported Q1 2025 GAAP revenue of $372 million (up 10%) and a net income per diluted share of $0.86. Non-GAAP net income rose 56% to $1.36 per share.
Why It Matters
Masimo's strong Q1 2025 results, with a 10% revenue increase and a 56% rise in non-GAAP net income, indicate robust growth, which could enhance investor confidence and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Masimo (MASI) reported quarterly earnings of $1.36 per share, exceeding the Zacks Consensus Estimate of $1.24 and up from $0.77 per share year-over-year.
Why It Matters
Masimo's earnings beat expectations and show significant year-over-year growth, indicating strong business performance and potential for future profitability, which can boost investor confidence.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Masimo's Q1 2025 results show strong performance in its Healthcare segment, despite challenges related to tariffs.
Why It Matters
Masimo's strong Q1 2025 results indicate robust performance in Healthcare, suggesting resilience against tariffs, which can enhance investor confidence and potentially drive stock value higher.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Frequently Asked Questions About MASI Stock
What is Masimo Corporation's (MASI) stock forecast for 2025?
Based on our analysis of 12 Wall Street analysts, Masimo Corporation (MASI) has a median price target of $182.50. The highest price target is $200.00 and the lowest is $158.00.
Is MASI stock a good investment in 2025?
According to current analyst ratings, MASI has 6 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $154.39. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MASI stock?
Wall Street analysts predict MASI stock could reach $182.50 in the next 12 months. This represents a 18.2% increase from the current price of $154.39. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Masimo Corporation's business model?
Masimo Corporation generates revenue primarily through the sale of advanced medical devices, particularly pulse oximetry systems, that enable healthcare providers to monitor patients' vital signs without invasive procedures. The company capitalizes on its proprietary technology to enhance patient outcomes and reduce healthcare costs, making its products essential in various medical settings.
What is the highest forecasted price for MASI Masimo Corporation?
The highest price target for MASI is $200.00 from Jason Bednar at Piper Sandler, which represents a 29.5% increase from the current price of $154.39.
What is the lowest forecasted price for MASI Masimo Corporation?
The lowest price target for MASI is $158.00 from at , which represents a 2.3% increase from the current price of $154.39.
What is the overall MASI consensus from analysts for Masimo Corporation?
The overall analyst consensus for MASI is bullish. Out of 12 Wall Street analysts, 6 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $182.50.
How accurate are MASI stock price projections?
Stock price projections, including those for Masimo Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 16, 2025 4:01 AM UTC